PE-backed Molbio’s Natarajan on revenue growth and why it isn't chasing M&As

Premium

India’s diagnostics sector has always been a sweet spot for investors and gained further traction from private equity players during the Covid-19 pandemic. Temasek- and Motilal Oswal PE-backed Molbio Diagnostics is no different.  Molbio attained a valuation of $1.6 billion last year when Temasek led an $85-million (around Rs 680 crore) ......